Based on previously described overexpression of proteasome subunits and excess proteasome activity in NSCLC cells expressing Onc-p53 protein (11), we investigated whether PIs exhibit preferential cytotoxicity in Onc-p53 NSCLC cells in vitro and in vivo. This evidence concerns the gene TP53 and non-small cell lung carcinoma.